Form 8-K - Current report:
SEC Accession No. 0001104659-25-032004
Filing Date
2025-04-04
Accepted
2025-04-04 08:30:21
Documents
13
Period of Report
2025-04-04
Items
Item 3.03: Material Modifications to Rights of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2511401d1_8k.htm   iXBRL 8-K 26346
  Complete submission text file 0001104659-25-032004.txt   198311

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA qnrx-20250404.xsd EX-101.SCH 3023
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE qnrx-20250404_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qnrx-20250404_pre.xml EX-101.PRE 22364
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2511401d1_8k_htm.xml XML 3634
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 8-K | Act: 34 | File No.: 001-37846 | Film No.: 25812131
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)